Hepatitis Monthly

Published by: Kowsar

Association Between IL-10 Gene Promoter Polymorphisms (-592 A/C, -819 T/C, -1082 A/G) and Susceptibility to HBV Infection in an Iranian Population

Bita Moudi 1 , 2 , Zahra Heidari 1 , 2 , * , Hamidreza Mahmoudzadeh-Sagheb 1 , 2 , Mohammad Hashemi 3 , 4 , Malihe Metanat 1 , 5 , Soheila Khosravi 6 and Parisa Farrokh 7
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Department of Histology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
3 Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
4 Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
5 Department of Infectious Diseases, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
6 Blood Transfusion Research Center, High Institute for Research and Education in Medicine, Zahedan, IR Iran
7 Department of Genetic, School of Biology, Damghan University, Damghan, IR Iran
Article information
  • Hepatitis Monthly: February 01, 2016, 16 (2); e32427
  • Published Online: February 20, 2016
  • Article Type: Research Article
  • Received: August 26, 2015
  • Revised: November 29, 2015
  • Accepted: January 9, 2016
  • DOI: 10.5812/hepatmon.32427

To Cite: Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Hashemi M, Metanat M, et al. Association Between IL-10 Gene Promoter Polymorphisms (-592 A/C, -819 T/C, -1082 A/G) and Susceptibility to HBV Infection in an Iranian Population, Hepat Mon. 2016 ;16(2):e32427. doi: 10.5812/hepatmon.32427.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008; 359(14): 1486-500[DOI][PubMed]
  • 2. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997; 337(24): 1733-45[DOI][PubMed]
  • 3. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107[PubMed]
  • 4. Liu Q, Song Y, Zhou Y, Qiao L. A useful agent for chemoprevention of hepatocellular carcinoma? Cancer Biol Ther. 2006; 5(12): 1674-6[PubMed]
  • 5. Hadziyannis SJ, Papatheodoridis GV, Vassilopoulos D. Precore mutant chronic hepatitis B - approach to management. MedGenMed. 2003; 5(4): 1[PubMed]
  • 6. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet. 2003; 362(9401): 2089-94[DOI][PubMed]
  • 7. Khanizadeh S, Ravanshad M, Mohebbi SR, Naghoosi H, Abrahim Tahaei M, Mousavi Nasab SD, et al. Polymorphisms within the Promoter Region of the Gamma Interferon (IFN-gamma) Receptor1 Gene are Associated with the Susceptibility to Chronic HBV Infection in an Iranian Population. Hepat Mon. 2012; 12(11)[DOI][PubMed]
  • 8. Karimi MH, Yaghobi R, Arjmandi K, Geramizadeh B, Nikeghbalian S, Malekhosseini SA. Cytokine gene polymorphisms and viral hepatitis infections in kidney transplant recipients. Lab Medicine. 2013; 44(2): 114-20
  • 9. Behelgardi A, Hosseini SM, Mohebbi SR, Azimzadeh P, Derakhshani S, Karimi K, et al. A Study on Genetic Association of Interleukin-16 Single Nucleotide Polymorphism (rs1131445) With Chronic Hepatitis B Virus Infection in Iranian Patients. Jundishapur J Microbiol. 2015; 8(11)
  • 10. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol. 2004; 22: 929-79[DOI][PubMed]
  • 11. Tsukamoto H. Is interleukin-10 antifibrogenic in chronic liver injury? Hepatology. 1998; 28(6): 1707-9[DOI][PubMed]
  • 12. Fonseca C, Lindahl GE, Ponticos M, Sestini P, Renzoni EA, Holmes AM, et al. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med. 2007; 357(12): 1210-20[DOI][PubMed]
  • 13. Yang J, Li CR, Li YB, Li RX, Sun LB, Huang HJ, et al. [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter]. Zhonghua Er Ke Za Zhi. 2003; 41(8): 598-602[PubMed]
  • 14. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics. 1997; 46(2): 120-8[PubMed]
  • 15. Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med. 1998; 30(5): 469-73[PubMed]
  • 16. D'Alfonso S, Rampi M, Rolando V, Giordano M, Momigliano-Richiardi P. New polymorphisms in the IL-10 promoter region. Genes Immun. 2000; 1(3): 231-3[DOI][PubMed]
  • 17. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol. 2001; 166(6): 3915-22[PubMed]
  • 18. Kube D, Rieth H, Eskdale J, Kremsner PG, Gallagher G. Structural characterisation of the distal 5' flanking region of the human interleukin-10 gene. Genes Immun. 2001; 2(4): 181-90[DOI][PubMed]
  • 19. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997; 24(1): 1-8[PubMed]
  • 20. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T. Differential regulation of interleukin-10 production by genetic and environmental factors--a twin study. Genes Immun. 2002; 3(7): 407-13[DOI][PubMed]
  • 21. Eskdale J, Kube D, Gallagher G. A second polymorphic dinucleotide repeat in the 5' flanking region of the human IL10 gene. Immunogenetics. 1996; 45(1): 82-3[PubMed]
  • 22. Koss K, Fanning GC, Welsh KI, Jewell DP. Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3' mismatches in forward and reverse primers. Genes Immun. 2000; 1(5): 321-4[DOI][PubMed]
  • 23. Tountas NA, Cominelli F. Identification and initial characterisation of two polymorphisms in the human interleukin-10 promoter. Eur Cytokine Netw. 1996; 7: 578
  • 24. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A. 1998; 95(16): 9465-70[PubMed]
  • 25. Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K, et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol. 2002; 97(8): 2086-92[DOI][PubMed]
  • 26. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology. 1999; 30(2): 526-30[DOI][PubMed]
  • 27. Afzal MS, Tahir S, Salman A, Baig TA, Shafi T, Zaidi NU, et al. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. J Infect Dev Ctries. 2011; 5(6): 473-9[PubMed]
  • 28. Peng XM, Huang YS, Ma HH, Gu L, Xie QF, Gao ZL. Interleukin-10 promoter polymorphisms are associated with the mode and sequel of HBeAg seroconversion in patients with chronic hepatitis B virus infection. Liver Int. 2006; 26(3): 326-33[DOI][PubMed]
  • 29. Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, et al. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol. 2006; 21(7): 1163-9[DOI][PubMed]
  • 30. Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, et al. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol. 2005; 42(4): 505-10[DOI][PubMed]
  • 31. Bagheri MMH, Sharifi Z, Sanati MH, Shahzadeh FA, Farhangnia M. The survey on-592 polymorphism of interlukin-10 in hepatitis b virus infected patients. J Isfahan Med School. 2014; 31(271): 1-8
  • 32. Gao QJ, Liu DW, Zhang SY, Jia M, Wang LM, Wu LH, et al. Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol. 2009; 15(44): 5610-9[PubMed]
  • 33. Yan Z, Tan W, Zhao W, Dan Y, Wang X, Mao Q, et al. Regulatory polymorphisms in the IL-10 gene promoter and HBV-related acute liver failure in the Chinese population. J Viral Hepat. 2009; 16(11): 775-83[DOI][PubMed]
  • 34. Persico M, De Renzo A, Persico E, Torella D, Rotoli B, Torella R. Chronic liver disease and lymphoproliferative disorders in HCV-positive patients: a working hypothesis. J Hepatol. 1998; 29(5): 857-8[PubMed]
  • 35. Xie HY, Wang WL, Yao MY, Yu SF, Feng XN, Jin J, et al. Polymorphisms in cytokine genes and their association with acute rejection and recurrence of hepatitis B in Chinese liver transplant recipients. Arch Med Res. 2008; 39(4): 420-8[DOI][PubMed]
  • 36. Ollier WE. Cytokine genes and disease susceptibility. Cytokine. 2004; 28(4-5): 174-8[DOI][PubMed]
  • 37. Hohler T, Reuss E, Freitag CM, Schneider PM. A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A. Hepatology. 2005; 42(1): 72-6[DOI][PubMed]
  • 38. Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology. 2001; 33(3): 708-12[DOI][PubMed]
  • 39. Oleksyk TK, Thio CL, Truelove AL, Goedert JJ, Donfield SM, Kirk GD, et al. Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance. Genes Immun. 2005; 6(4): 347-57[DOI][PubMed]
  • 40. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology. 2000; 31(4): 828-33[DOI][PubMed]
  • 41. Constantini PK, Wawrzynowicz-Syczewska M, Clare M, Boron-Kaczmarska A, McFarlane IG, Cramp ME, et al. Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy. Liver. 2002; 22(5): 404-12[PubMed]
  • 42. Truelove AL, Oleksyk TK, Shrestha S, Thio CL, Goedert JJ, Donfield SM, et al. Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet. 2008; 35(3): 255-64[DOI][PubMed]
  • 43. Srivastava M, Ranjan A, Choudhary JK, Tripathi MK, Verma S, Dixit VK, et al. Role of proinflammatory cytokines (interferon gamma) and anti-inflammatory cytokine (interleukin-10) gene polymorphisms in chronic hepatitis B infection: an Indian scenario. J Interferon Cytokine Res. 2014; 34(7): 547-51[DOI][PubMed]
  • 44. Wang S, Huang D, Sun S, Ma W, Zhen Q. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa. Virol J. 2011; 8: 28[DOI][PubMed]
  • 45. Ghaleh Baghi S, Alavian SM, Mehrnoush L, Salimi S. Impact of the IL-10 Promoter Gene Polymorphisms in the Severity of Chronic Hepatitis B Infection. Hepat Mon. 2015; 15(7)[DOI][PubMed]
  • 46. Sofian M, Kalantar E, Aghakhani A, Hosseini S, Banifazl M, Eslamifar A, et al. No correlation between interleukin-10 gene promoter polymorphisms and hepatitis B virus infection outcome. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 47. Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R, et al. Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine. 2006; 34(1-2): 24-31[DOI][PubMed]
  • 48. Chuang JY, Yang SS, Lu YT, Hsieh YY, Chen CY, Chang SC, et al. IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients. Dig Liver Dis. 2009; 41(6): 424-30[DOI][PubMed]
  • 49. Shin HD, Park BL, Kim LH, Jung JH, Kim JY, Yoon JH, et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet. 2003; 12(8): 901-6[PubMed]
  • 50. Wu JF, Ni YH, Lin YT, Lee TJ, Hsu SH, Chen HL, et al. Human interleukin-10 genotypes are associated with different precore/core gene mutation patterns in children with chronic hepatitis B virus infection. J Pediatr. 2011; 158(5): 808-13[DOI][PubMed]
  • 51. Lu YL, Wu X, Huang HL, Dai LC. Allele polymorphisms of interleukin-10 and hepatitis B, C virus infection. Chin Med J (Engl). 2010; 123(10): 1338-44[PubMed]
  • 52. Zhang PA, Li Y, Yang XS. [Associated study on interleukin 10 gene promoter polymorphisms related to hepatitis B virus infection in Chinese Han population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006; 23(4): 410-4[PubMed]
  • 53. Mangia A, Santoro R, Piattelli M, Pazienza V, Grifa G, Iacobellis A, et al. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine. 2004; 25(3): 103-9[PubMed]
  • 54. Fickenscher H, Hor S, Kupers H, Knappe A, Wittmann S, Sticht H. The interleukin-10 family of cytokines. Trends Immunol. 2002; 23(2): 89-96[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments